Generics in Canada
Generics in Canada
SUMMARY
Generics in Canada industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Generics in Canada industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The Canadian generics market had total revenues of $5.2bn in 2019, representing a compound annual growth rate (CAGR) of 2.5% between 2015 and 2019.
- Market consumption volume increased with a CAGR of 1.5% between 2015 and 2019, to reach a total of 73% in 2019.
- Canada has some of the highest prices charged for generics in the world, which means that revenues can be large, but provinces are working together to work out how they can make the system fairer and improve access to cheaper medication.
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in Canada
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Canada
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Canada generics market with five year forecasts by both value and volume
- What was the size of the Canada generics market by value in 2019?
- What will be the size of the Canada generics market in 2024?
- What factors are affecting the strength of competition in the Canada generics market?
- How has the market performed over the last five years?
- How large is Canada’s generics market in relation to its regional counterparts?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
3.2. Market volume
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
5.2. Market volume forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. How has the outbreak of COVID-19 impacted leading players?
8 COMPANY PROFILES
8.1. Pfizer Inc.
8.2. Teva Pharmaceutical Industries Limited
8.3. Apotex, Inc.
8.4. Mylan N.V.
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
3.2. Market volume
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
5.2. Market volume forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. How has the outbreak of COVID-19 impacted leading players?
8 COMPANY PROFILES
8.1. Pfizer Inc.
8.2. Teva Pharmaceutical Industries Limited
8.3. Apotex, Inc.
8.4. Mylan N.V.
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Canada generics market value: $ million, 2015-19
Table 2: Canada generics market volume: % of total pharma, 2015-19
Table 3: Canada generics market geography segmentation: $ million, 2019
Table 4: Canada generics market value forecast: $ million, 2019-24
Table 5: Canada generics market volume forecast: % of total pharma, 2019-24
Table 6: Pfizer Inc.: key facts
Table 7: Pfizer Inc.: Annual Financial Ratios
Table 8: Pfizer Inc.: Key Employees
Table 9: Pfizer Inc.: Key Employees Continued
Table 10: Teva Pharmaceutical Industries Limited: key facts
Table 11: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 12: Teva Pharmaceutical Industries Limited: Key Employees
Table 13: Apotex, Inc.: key facts
Table 14: Apotex, Inc.: Key Employees
Table 15: Mylan N.V.: key facts
Table 16: Mylan N.V.: Annual Financial Ratios
Table 17: Mylan N.V.: Key Employees
Table 18: Canada size of population (million), 2015-19
Table 19: Canada gdp (constant 2005 prices, $ billion), 2015-19
Table 20: Canada gdp (current prices, $ billion), 2015-19
Table 21: Canada inflation, 2015-19
Table 22: Canada consumer price index (absolute), 2015-19
Table 23: Canada exchange rate, 2015-19
Table 1: Canada generics market value: $ million, 2015-19
Table 2: Canada generics market volume: % of total pharma, 2015-19
Table 3: Canada generics market geography segmentation: $ million, 2019
Table 4: Canada generics market value forecast: $ million, 2019-24
Table 5: Canada generics market volume forecast: % of total pharma, 2019-24
Table 6: Pfizer Inc.: key facts
Table 7: Pfizer Inc.: Annual Financial Ratios
Table 8: Pfizer Inc.: Key Employees
Table 9: Pfizer Inc.: Key Employees Continued
Table 10: Teva Pharmaceutical Industries Limited: key facts
Table 11: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 12: Teva Pharmaceutical Industries Limited: Key Employees
Table 13: Apotex, Inc.: key facts
Table 14: Apotex, Inc.: Key Employees
Table 15: Mylan N.V.: key facts
Table 16: Mylan N.V.: Annual Financial Ratios
Table 17: Mylan N.V.: Key Employees
Table 18: Canada size of population (million), 2015-19
Table 19: Canada gdp (constant 2005 prices, $ billion), 2015-19
Table 20: Canada gdp (current prices, $ billion), 2015-19
Table 21: Canada inflation, 2015-19
Table 22: Canada consumer price index (absolute), 2015-19
Table 23: Canada exchange rate, 2015-19
LIST OF FIGURES
Figure 1: Canada generics market value: $ million, 2015-19
Figure 2: Canada generics market volume: % of total pharma, 2015-19
Figure 3: Canada generics market geography segmentation: % share, by value, 2019
Figure 4: Canada generics market value forecast: $ million, 2019-24
Figure 5: Canada generics market volume forecast: % of total pharma, 2019-24
Figure 6: Forces driving competition in the generics market in Canada, 2019
Figure 7: Drivers of buyer power in the generics market in Canada, 2019
Figure 8: Drivers of supplier power in the generics market in Canada, 2019
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Canada, 2019
Figure 10: Factors influencing the threat of substitutes in the generics market in Canada, 2019
Figure 11: Drivers of degree of rivalry in the generics market in Canada, 2019
Figure 1: Canada generics market value: $ million, 2015-19
Figure 2: Canada generics market volume: % of total pharma, 2015-19
Figure 3: Canada generics market geography segmentation: % share, by value, 2019
Figure 4: Canada generics market value forecast: $ million, 2019-24
Figure 5: Canada generics market volume forecast: % of total pharma, 2019-24
Figure 6: Forces driving competition in the generics market in Canada, 2019
Figure 7: Drivers of buyer power in the generics market in Canada, 2019
Figure 8: Drivers of supplier power in the generics market in Canada, 2019
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Canada, 2019
Figure 10: Factors influencing the threat of substitutes in the generics market in Canada, 2019
Figure 11: Drivers of degree of rivalry in the generics market in Canada, 2019
